Influence of GSTP-1 Polymorphism on the Prognosis of Patients with High-Grade Glioma Who Received Te...
Influence of GSTP-1 Polymorphism on the Prognosis of Patients with High-Grade Glioma Who Received Temozolomide Plus Radiotherapy Adjuvant Treatment Influence of GSTP-1 Polymorphism on the Prognosis of Patients with High-Grade Glioma Who Received Temozolomide Plus Radiotherapy Adjuvant Treatment
About this item
Full title
Publisher
Dove Medical Press
Journal title
Language
English
Formats
Publication information
Publisher
Dove Medical Press
Subjects
More information
Scope and Contents
Contents
De-Bao Zhi,1,* Zhi-Yu Wang,2,* Tong Xie,1 Wen-Wen Tu1 1Department of Surgical Care Unit, Xuhui District Central Hospital, Shanghai, 200031, People’s Republic of China; 2Department of Neurosurgery, Xuhui District Central Hospital, Shanghai, 200031, People’s Republic of China*These authors contributed equally to this workCorrespondence: De-Bao Zhi Te...
Alternative Titles
Full title
Influence of GSTP-1 Polymorphism on the Prognosis of Patients with High-Grade Glioma Who Received Temozolomide Plus Radiotherapy Adjuvant Treatment Influence of GSTP-1 Polymorphism on the Prognosis of Patients with High-Grade Glioma Who Received Temozolomide Plus Radiotherapy Adjuvant Treatment
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5fbb1ae01a0d44c4b6af6c2522b55079
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5fbb1ae01a0d44c4b6af6c2522b55079
Other Identifiers
ISSN
1178-7074
E-ISSN
1178-7074
